background image

Liver Cancer Clinical Trials

Find clinical trials for liver cancer. Search for liver cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

for
Breast Cancer, Liver Cancer, Prostate Cancer
Location: 3 recruiting locations
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 21+

Code: NCT05146297

Recruiting
Active & Responsive

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

for
Liver Neoplasms, Primary Liver Cancer, Secondary Liver Cancer,
Location: 20 recruiting locations
Sponsor: HistoSonics, Inc.

Sex: All

Age: 22+

Code: NCT06486454

Recruiting
Active & Responsive

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

for
Advanced Liver Cancers
Location: 12 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT04524871

Phase1, Phase2, Recruiting
Active & Responsive

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

for
Metastatic Colorectal Cancer, Hepatocellular Carcinoma
Location: 1 recruiting location
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06553885

Phase2, Recruiting
Active & Responsive

Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)

for
Hepatocellular Carcinoma
Location: 1 recruiting location
Sponsor: Anwaar Saeed

Sex: All

Age: 18+

Code: NCT06698250

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

for
Locally Advanced Hepatocellular Carcinoma,
Location: 9 recruiting locations
Sponsor: Academic and Community Cancer Research United

Sex: All

Age: 18+

Code: NCT05168163

Phase2, Recruiting
Active & Responsive

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Location: 1 recruiting location
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT04248569

Phase1, Recruiting
Active & Responsive

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

for
Fibrolamellar Hepatocellular Carcinoma
Location: 1 recruiting location
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT06027086

Phase1, Phase2, Recruiting
Active & Responsive

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

for
Pleural Effusion, Malignant, Ascites, Malignant, Carcinoma,
Location: 1 recruiting location
Sponsor: Travera Inc

Sex: All

Age: 18+

Code: NCT05461430

Recruiting
Active & Responsive

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: 8 recruiting locations
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase1, Phase2, Recruiting